Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 3Sarcoma 2Other solid neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningeal Neoplasms 1Medulloblastoma 1Hepatoblastoma 1

Interventions

Filgrastim 6Granulocyte Colony-Stimulating Factor 5Carboplatin 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Etoposide 3Cyclophosphamide 3Topotecan 2racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1cixutumumab 1becatecarin 1alvocidib 1Vincristine 1Thrombopoietin 1Temozolomide 1Sirolimus 1Simvastatin 1Radiotherapy 1Nivolumab 1Methotrexate 1Melphalan 1Leucovorin 1LY2940680 1Itraconazole 1Immunologic Techniques 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × omburtamab I-131 × Other solid neoplasm × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡